<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e>-specific biomarkers have been used as molecular targets for fluorescent intra-operative imaging, targeted PET/MRI, and selective cytotoxic drug delivery yet the selection of biomarkers used is rarely evidence-based </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated sensitivities and specificites of four of the most commonly used markers: carcinoembryonic antigen (CEA), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated <z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-72 (TAG-72), <z:chebi fb="3" ids="37445">folate</z:chebi> receptor-α (FRα) and Epithelial growth factor receptor (EGFR) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Marker expression was evaluated semi-quantitatively in matched mucosal and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissues from 280 patients using immunohistochemistry (scores of 0-15) </plain></SENT>
<SENT sid="3" pm="."><plain>Matched positive and negative lymph nodes from 18 patients were also examined </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Markers were more highly expressed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue than in matched <z:mpath ids='MPATH_458'>normal</z:mpath> tissue in 98.8%, 79.0%, 37.1% and 32.8% of cases for CEA, TAG-72, FRα and EGFR, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>Carcinoembryonic antigen showed the greatest differential expression, with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> scoring a mean of 10.8 points higher than <z:mpath ids='MPATH_458'>normal</z:mpath> tissues (95% CI 10.31-11.21, P&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, CEA showed the greatest differential expression between positive and negative lymph nodes </plain></SENT>
<SENT sid="7" pm="."><plain>Receiver operating characteristic analyses showed CEA to have the best sensitivity (93.7%) and specificity (96.1%) for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> detection </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: Carcinoembryonic antigen has the greatest potential to allow highly specific <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> imaging and drug delivery; future translational research should aim to exploit this </plain></SENT>
</text></document>